facebook
twitter
rss
account
search
search
 

Grassley warns FDA against whistleblower retaliation

Nov. 29, 2004 at 3:52 PM   |   Comments

WASHINGTON, Nov. 29 (UPI) -- Senate Finance Committee Chairman Chuck Grassley, R-Iowa, has warned the Food and Drug Administration not to retaliate against an agency whistleblower.

In a letter Monday to Acting FDA Commissioner Lester Crawford, Grassley noted allegations that retaliatory actions may be taken against David Graham. An official in the FDA's Office of Drug Safety, Graham testified before a Congressional committee Nov. 18 that the agency is not doing enough to protect the public from dangerous medications.

Grassley asked Crawford to address allegations Graham may be terminated or transferred from his position against his wishes.

Graham testified the agency attempted to suppress his research showing the dangers of the arthritis drug Vioxx, which was recently pulled from the market. He warned that five other prescription medications should also be removed from the market or, at least, carry stronger use restrictions.

© 2004 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Most Popular
1
China questions Americanism in SATs
2
Dairy Queen hit by Backoff malware breach
3
Plague bomb data found on seized Islamic State laptop
4
St. Paul police arrest a black man for sitting on a bench waiting for his children
5
Brazil Air Force, Saab discuss Gripen procurement deal
Trending News
Video
x
Feedback